Phase I trial of continuous infusion flavopiridol, a novel cyclin- dependent kinase inhibitor, in patients with refractory neoplasms

Adrian M. Senderowicz*, Donna Headlee, Sherman F. Stinson, Richard M. Lush, Nelson Kalil, Lourdes Villalba, Kimberly Hill, Seth M. Steinberg, William D. Figg, Anne Tompkins, Susan G. Arbuck, Edward A. Sausville

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

399 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I trial of continuous infusion flavopiridol, a novel cyclin- dependent kinase inhibitor, in patients with refractory neoplasms'. Together they form a unique fingerprint.

Medicine & Life Sciences